Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lazarus

Showing results (851-860 of 881) with videos related to

Pageof 89
Sort By:
The New England Journal of Medicine|March 17, 2021
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 AcquisitionLawrence Corey, Peter B Gilbert, Michal Juraska, et al.
Haematologica|February 13, 2023
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosisGuru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, et al.
The New England Journal of Medicine|July 24, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in AdultsMark R Litzow, Zhuoxin Sun, Ryan J Mattison, et al.
Leukemia|October 31, 2022
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patientsMichael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2014
Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survivalBrian L McClune, Kwang Woo Ahn, Hai-Lin Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2013
Salvage second hematopoietic cell transplantation in myelomaLaura C Michaelis, Ayman Saad, Xiaobo Zhong, et al.
Transplantation and Cellular Therapy|August 24, 2021
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in AdultsLeland Metheny, Natalie S Callander, Aric C Hall, et al.
JAMA Oncology|January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated DonorsGuru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 4, 2011
Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research studyPhilippe Armand, Haesook T Kim, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2019
Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant ResearchDavid Buchbinder, Ruta Brazauskas, Khalid Bo-Subait, et al.
Pageof 89

Showing results (851-860 of 881) with videos related to

Sort By:
Pageof 89
The New England Journal of Medicine|March 17, 2021
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 AcquisitionLawrence Corey, Peter B Gilbert, Michal Juraska, et al.
Haematologica|February 13, 2023
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosisGuru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, et al.
The New England Journal of Medicine|July 24, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in AdultsMark R Litzow, Zhuoxin Sun, Ryan J Mattison, et al.
Leukemia|October 31, 2022
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patientsMichael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2014
Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survivalBrian L McClune, Kwang Woo Ahn, Hai-Lin Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2013
Salvage second hematopoietic cell transplantation in myelomaLaura C Michaelis, Ayman Saad, Xiaobo Zhong, et al.
Transplantation and Cellular Therapy|August 24, 2021
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in AdultsLeland Metheny, Natalie S Callander, Aric C Hall, et al.
JAMA Oncology|January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated DonorsGuru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 4, 2011
Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research studyPhilippe Armand, Haesook T Kim, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2019
Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant ResearchDavid Buchbinder, Ruta Brazauskas, Khalid Bo-Subait, et al.
Pageof 89